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How to measure premature mortality? 
A proposal combining “relative” and “absolute” 
approaches
S. Stefano Mazzuco1* , M. Marc Suhrcke2,3 and L. Lucia Zanotto4 
Abstract 
Background: The concept of “premature mortality” is at the heart of many national and global health measurement 
and benchmarking efforts. However, despite the intuitive appeal of its underlying concept, it is far from obvious how 
to best operationalise it. The previous work offers at least two basic approaches: an absolute and a relative one. The 
former—and far more widely used— approach sets a unique age threshold (e.g. 65 years), below which deaths are 
defined as premature. The relative approach derives the share of premature deaths from the country-specific age 
distribution of deaths in the country of interest. The biggest disadvantage of the absolute approach is that of using 
a unique, arbitrary threshold for different mortality patterns, while the main disadvantage of the relative approach is 
that its estimate of premature mortality strongly depends on how the senescent deaths distribution is defined in each 
country.
Method: We propose to overcome some of the downsides of the existing approaches, by combining features of 
both, using a hierarchical model, in which senescent deaths distribution is held constant for each country as a pivotal 
quantity and the premature mortality distribution is allowed to vary across countries. In this way, premature mortality 
estimates become more comparable across countries with similar characteristics.
Results: The proposed hierarchical models provide results, which appear to align with related evidence from  specific 
countries. In particular, we find a relatively high premature mortality for the United States and Denmark.
Conclusions: While our hybrid approach overcomes some of the problems of previous measures, some issues 
require further research, in particular the choice of the group of countries that a given country is assigned to and the 
choice of the benchmarks within the groups. Hence, our proposed method, combined with further study addressing 
these issues, could provide a valid alternative way to measure and compare premature mortality across countries.
Keywords: Premature mortality, Mixture model, Hierarchical model
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Background
“Premature mortality” is a highly popular metric of 
population health, widely used, e.g. for the purpose of 
international and country-level performance assess-
ments interested in capturing some dimension of an 
“unnecessary” or “avoidable” burden of mortality. It 
features prominently, for instance, as a target of Sus-
tainable Development Goal 3 (“Ensure healthy lives 
and promote wellbeing for all at all ages”).1 Quantify-
ing premature mortality can be useful from a policy 
Open Access
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1 The health target 3.4 is about reducing, by 2030, by one third the premature 
mortality from non-communicable diseases through prevention and treat-
ment and promote mental health and well-being [1].
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perspective, too, in that a particularly high level—or 
a rising trend—in premature mortality may alert poli-
cymakers to an underlying population health problem. 
However, while the concept is intuitively convinc-
ing and potentially informative to policy, premature 
mortality is hard to measure unambiguously, given its 
latent nature. In practice, several different measures 
of premature mortality are in circulation. For example, 
the OECD measures premature mortality in terms of 
potential years of life lost (PYLL) before the age 70 [2]. 
Similarly, the Global Burden of Disease Study [3] uses 
the “Years of Life Lost” (YLL) as its proxy for prema-
ture mortality, which is calculated from the number of 
deaths multiplied by a global standard life expectancy 
at the age at which death occurs. The WHO consid-
ers an age-standardised overall mortality rate from 
age 30 to under 70 years [4], while Eurostat favours an 
age-standardized rate below age 65 [5]. In the demo-
graphic literature, a very different, more “endoge-
nous” approach is used, distinguishing a distribution 
of “natural” deaths from that of premature deaths, as 
first suggested by Lexis [6], and more recently consid-
ered by Kannisto [7, 8] and Cheung et  al [9]. In this 
perspective, there is no exogenous age threshold, but 
only two—partially overlapping—curves of mortal-
ity. These two fundamentally different approaches in 
defining and measuring premature mortality may be 
referred to as “absolute” and “relative” approaches, 
respectively. While the “absolute” approach uses a 
fixed age threshold to distinguish between “prema-
ture” and “senescent” deaths, the “relative” approach 
does not define any age threshold, but derives prema-
ture mortality on the basis of the age distribution of 
deaths.
The advantage (and likely appeal) of the “absolute” 
approach is in its straightforward implementation and 
interpretation, once the decision on the age threshold 
is taken. Yet, it is far from clear how the age threshold 
should be selected, and—more importantly—the choice 
of specific threshold may critically determine how coun-
tries compare against each other in terms of prema-
ture mortality. By contrast, the “relative” approach does 
not suffer from the challenge of setting an arbitrary age 
threshold, though at the cost of a more difficult interpre-
tation of what a “mature” or “normal” death, as defined 
by Lexis [6], really means. Moreover, cross-country com-
parisons are difficult to implement, since the extent of 
premature mortality depends on the senescent mortality, 
which substantially varies across countries.
In this paper, we acknowledge that both approaches 
have strengths and weaknesses, leading us to propose 
a third way, which may be considered as a constructive 
compromise between the two.
Premature mortality: an absolute view
The “absolute approach” to measuring premature mor-
tality is the method used by major international institu-
tions that engage in burden of disease and health system 
performance measurement [e.g. 4, 10, 11]. This approach 
involves fixing a certain age threshold, below which every 
death is defined as “premature”. Unfortunately, there is no 
clear consensus on what this threshold should be: some 
use 65 years [12], others 70 years and yet others use 75 
years of age [13]. Figure  1 illustrates how changing the 
threshold might well change the ranking of countries: 
while in Ireland, the below age 75 and below age 65 death 
rates are very close to each other, and the gap is much 
greater between the two measures for Portugal. Hence, 
when using the age 75 threshold, Portugal shows a lower 
rate of premature deaths than Ireland. This ranking is 
reversed, if we apply an age 65 threshold. More generally, 
a fixed cut-off does not take into account the specific fea-
tures of the overall mortality of a given country: a 65-year 
threshold might seem inadequate for countries charac-
terized by high life expectancy (e.g. Sweden or Japan), 
while a 75-year threshold clearly is not suited for coun-
tries with a life expectancy close to or below 75 years (e.g. 
Argentina or Brazil).
Several related to premature mortality concepts are 
based on fixing an age threshold: “midlife mortality”, 
for instance, which is sometimes defined as the mortal-
ity rate at age 45–54 and has been recently used to show 
a rising trend in the  USA [see 14], while Eurostat uses 
also “amenable” and “preventable” deaths [see 10, 11]. In 
essence, amenable deaths capture those causes of deaths 
that could have been avoided with adequate treatment, 
while preventable deaths could have been avoided by 
improved preventive behaviors or measures (i.e. reduced 
smoking, healthier diets, screening).
A further popular “absolute” measure for premature 
mortality is the Potential Years of Life Lost (PYLL), cal-
culated by multiplying the number of deaths at each age 
by the number of potential years remaining for that age. 
Yet also in this case, an ultimately arbitrary cut-off age 
has to be selected [15]. A possible choice could be using 
the average current life expectancy in the given popula-
tion. However, in a comparative perspective, it would be 
difficult to choose a different threshold for every country. 
This has led some authors to use a so-called “standard life 
expectancy” (SLE) [16], i.e. a life expectancy represent-
ing the potential maximum life span at a given age. The 
value of SLE ranges from 86.01 year (using GBD 2010 
study) to (91.93 using WHO Global Health Estimates), 
see [16]. Although this procedure seems less arbitrary 
than others, it remains at least debatable whether deaths 
at ages between 80 and 90 may be considered as truly 
“premature”, especially in the context of countries with a 





































































Fig. 1 Premature mortality, Ireland and Portugal mortality rates with different age threshold (panel a: age threshold: 65, panel b: age threshold: 75) 
(source: Own elaborations from HMD)
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relatively low average lifespan. This is not merely a philo-
sophical concern: the distinction of premature mortal-
ity from senescent one is important from a public health 
perspective, because the causes and the underlying risks 
factors associated with them are different. As an example, 
the rising concern in the US on “deaths of despair” [see 
17] derives from analysis of midlife mortality, for which 
external causes, e.g. suicide, drug and alcohol attributable 
deaths are particularly relevant. Therefore, while making 
a distinction between premature and senescent deaths is 
important, choosing a meaningful age-threshold remains 
contentious.
Premature mortality: a relative view
A very different approach to achieve the aim traces back 
to Lexis [6], who suggested that premature mortality 
could be measured by considering the age distribution of 
deaths (i.e. the death counts of the life table): according to 
Lexis, in the absence of premature mortality, this distribu-
tion should have a symmetric shape. Thus, the last, most 
right-hand part of the curve (from the modal age at death 
up to the end) can be “unfolded” to the left in order to 
obtain the hypothetical curve without premature deaths 
(called “normal deaths” by Lexis). Premature mortality in 
this sense is then measured as the difference between the 
actual and the hypothetical curve [see 9]. This may be seen 
as a “relative” measure, as the share2 of “premature” deaths 
depends on the whole distribution of deaths by age. Lexis’ 
idea was criticized and further elaborated by Pearson [18], 
who highlighted that also the hypothetical dx curve in the 
absence of premature mortality is not necessarily symmet-
ric. Therefore, he suggested a more complex curve to fit 
premature mortality. Figure 2 shows graphically the differ-
ence between the two approaches.
More recently, Zanotto et  al. [19] implemented a 
mixture model taking into account Pearson’s reason-
ing. This model is embedded in an growing literature 
that  considers the life table age-at-death distribution 
as a convenient function to fit, in the spirit of recent 
research by Basellini and Camarda [20], Mazzuco et al. 
[21] and Pascariu et  al. [22]. The proposed mixture 
model comprises three components of mortality:
(1)

































Equations (1–3) define two distributions: fM is the age at 
death distribution related to old age (henceforth called 
“senescent” mortality function) and fm , which is the age-
at-death distribution of premature mortality. Note that 
fm and fM are defined with two skewed normal distri-
butions, i.e. a generalization of the normal distribution, 
allowing for skewness [see 23]. These components are 
then combined to fit the age distribution of deaths, as 
follows:
The share of premature mortality is given by the estimate 
of parameter α . It should be noted that there exists a sig-
nificant literature that models mortality by decomposing 
the mortality age patterns into three components: Siler 
[24] and Heligman and Pollard [25] already provided 
such a decomposition with two different models several 
decades ago. More recently, Basellini and Camarda [26] 
also proposed a three-component model. However, in 
none of these cases do the models yield an estimate of 
premature mortality. The Heligman and Pollard model is 
more related to accident-attributable mortality, which is 
a quite different concept, as it is mainly related to exter-
nal causes of deaths, and it is concentrated in the younger 
adulthood age range (see Remund et al. [27] for a detailed 
analysis of this component), while premature mortality 
is a broader concept, involving more causes of death and 
older ages. Siler’s model assumes a constant mortality 
rate during young adulthood, while the Basellini–Cama-
rda model is more flexible, using the Lee-Carter model 
applied to each component (childhood, early-adulthood 
and senescent), it nonetheless does not allow for a quan-
tification of premature mortality.
The advantage of the approach underlying model 4 is 
that defining an age threshold separating “normal” deaths 
from premature ones is no longer needed, but premature 
deaths are defined as the number of deaths that let the 
real distribution of deaths exceed the hypothetical one, as 
illustrated in Fig. 2.
We coin this the “relative” approach, as the premature 
mortality share also depends on how old-age deaths are 
distributed: if they are shifted to the right, deaths on 
the right-hand  side of the mode are more likely to be 
included in the premature deaths distributions. Thus, 
in the relative approach, the exact operationalization of 













d(x) = η · fI (x)
+ (1 − η) · α · fm(x, ξm,ωm, m)
+ (1 − η) · (1 − α) · fM(x, ξM ,ωM , M)
2 Note that in this way premature deaths are not individually identified, but 
only the total share is calculated.
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“senescent” mortality, and every country has its own pat-
tern of “senescent” and premature deaths distributions. 
In this way, we avoid defining a universal threshold that 
might be questionable for some countries. On the other 
hand, the relative approach implicitly admits that a death 
can be deemed as premature—and hence “deserving” to 
be avoided in one country, and not in another one. This 
may be seen as problematic from an ethical perspec-
tive. Yet, there is also a more practical concern to this 
approach: if we draw a comparison between, for instance, 
France and USA, we find a result that may seem surpris-
ing (see Fig. 3): the share of premature deaths in France 
is much higher than that of the USA, and increasing in 
recent years—a result that is at odds with what may be 
our knowledge about lifespan in these two countries. 
France is a high longevity country and recent literature 
shows that premature mortality has declined (rather than  
increased) in the last years [28], while it is well-known 
that the USA has a lower life expectancy and a relatively 
high level of premature (or mid-life) mortality [14, 29].
The explanation of Fig. 3 is that in France the “normal” 
deaths shifted to the right in the last decades, and this 
probably produced the increase in the share of prema-
ture deaths (i.e. deaths that before were included among 






























































Fig. 2 Two views for measuring premature mortality (red area) considering a relative framework
Page 6 of 14Mazzuco et al. Popul Health Metrics           (2021) 19:41 
the “normal” ones are now deemed as premature). In the 
USA, instead, the “normal” deaths distribution is located 
far more to the left, thus encompassing also deaths that 
in France would be more likely considered as “prema-
ture”. Figure 4 shows that, surprisingly, the relative meas-
ure defined by equation (4) suggests an increasing trend 
of premature mortality (data provided by Human Mortal-
ity Database—HMD). Even more striking is that France 
is one of the countries showing the sharpest increase of 
premature mortality in recent years, while the USA share 
of premature deaths has stabilized somewhat.
Hence, while on the one hand, the relative approach 
eliminates the difficult choice of the age threshold, allow-
ing for better comparison between countries with differ-
ent levels of life expectancy, this may come at the cost 
of producing counter-intuitive results. The explanation 
of the latter is that with this approach, the share of pre-
mature deaths depends also on the shape and location 
of the senescent curve ( fM ). Hence if fM has a relatively 
large variance and low mean (as we observe in the USA), 
it might be that the “premature” curve is hidden by the 
senescent one and so underestimated, while in coun-
tries where senescent deaths shift to the right and are 
highly compressed (like in France), the area of prema-
ture mortality is isolated and more visible, but probably 
overestimated.
Methods
Both “relative” and “absolute” approaches have revealed 
some pitfalls that render the comparison of premature 
mortality difficult across countries. In this section, we 
present an alternative approach that seeks to combine the 
positive aspects of either previous approach, while trying 
to avoid their respective drawbacks. To this end, we pro-
pose to group some comparable countries and assume 
that all of them have the same senescent mortality curve, 
while the premature mortality curve is allowed to vary 
across countries. This choice is in line with the idea by Li 
and Lee [30], who apply the Lee-Carter model to a group 
of populations, allowing each its own age pattern and 
level of mortality but imposing shared rates of change by 
age by adding a common factor. This choice may be justi-
fied by the rapid diffusion that innovations in the public 
health sector can have, leading to a relatively swift diffu-
sion of a longevity improvement in one country to others 
of the same group. Thus, we similarly assume that coun-
tries of the same group should have an equal senescent 
distribution (the common factor), while the premature 
curve will be country-specific. In this way, the prema-
ture mortality of each country will be easier to compare, 
as they all will be the complement of the same senescent 
function.
This will be achieved by constructing a hierarchi-
cal model, where premature mortality coefficients are 
allowed to vary across countries, while senescent mortal-
ity parameters remain fixed, according  to the equation3
Model (5) is estimated with a Bayesian approach, so prior 
(and hyper-priors) distributions are defined as follows:
(5)









+ (1 − αj) · f
M(x,µM , σM , γM).
(6)
αj ∼ U(0, 0.9)
µmj ∼ N (60, σ
2
µm)T [−∞, 75]
σmj ∼ U(0, 20)
γmj ∼ N (0, σ
2
γm)T [−0.8, 0.995]
µM ∼ N (87, 4)
σM ∼ U(0, 9)
γM ∼ SN (−1, 0.5, 1)T [−0.995, 0.995]
σµm ∼ U(0, 2.5)





























































Fig. 3 France and USA 2011, Senescent and premature mortality 
curves using the relative approach (source: Own elaborations from 
HMD)
3 For simplicity infant mortality component is disregarded and model has 
been fitted only on death occurring at age 5 and higher.
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where dj(x) is the distribution of deaths by age x in 
the life table of country j. We use life table d(x) rather 
observed deaths because the latter are confounded by 
the age structure of populations, while the former are 
standardized with respect to age structure. Here, infant 
and child mortality is disregarded so dj(x) is the distribu-
tion only of deaths above age 5. fm and fM are two skew-
normal probability distribution functions with so-called 
“centered parametrization” [see 31]. These represent the 
distribution of premature and senescent deaths, which 
are mixed with mixture parameter αj . It can be noted that 
while parameters of fm depends on j, parameters of fM do 
not, which means that we assume that senescent compo-
nent ( fM ) remains fixed across countries, and the prema-
ture one ( fm ) varies across countries.
As far as prior specification is concerned, mean and 
skewness parameters ( µm,µM and γm ) are normally dis-
tributed, while γM is skew-normally distributed, standard 
deviations ( σm and σM ) and the mixture parameter ( α , 
which is our parameter of interest) are uniformly distrib-
uted. Note that most of the priors are non-informative, 
although some of them have been given a low variance 
to avoid identification and label-switching problems. For 
the same reasons, we truncated some priors: the mean of 
premature mortality curve, for instance, cannot exceed 
75 and its skewness cannot be below -0.8. It should be 
kept in mind that the skewness parameter is bounded 
between -0.995 and 0.995. We did not report results of 
sensitivity checks we have made, in particular by chang-
ing the variance of priors, getting the same results. This 
was not a surprise, given the high sample size of our data 
and that it is well known that in these cases the likelihood 
tends to dominate the prior information. However, the 
issue of prior sensitivity might be more relevant when 


























































































































































































































































































































Fig. 4 Prevalence of premature mortality in selected high-income countries, using the relative approach (source: Own elaborations from HMD)
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with lower sample size. In those cases, sensitivity might 
be higher.
Models have been fitted in R and STAN software, and 
the code is available at github repository (https:// github. 
com/ stefa nomaz zuco/ Prema ture_ Hiera rchic al).
This approach also overcomes the ethical issue raised 
in section "Premature mortality: a relative view", since 
deaths at a given age will be equally considered in differ-
ent countries, as long as they belong to the same group. 
This will be further discussed in the next sections.
Results
We apply this method to data from HMD, considering 
the countries suggested by Li and Lee [30]. Results are 
summarized in Fig.  5 and, in addition, the comparison 
between France and USA is also shown (Fig.  6), which, 
in contrast to Fig. 3 shows that France has a much lower 
share of premature mortality compared to the USA. The 
comparison between Figs.  3 and 6 also shows that two 
similar fits of observed data can  yield two quite differ-
ent estimates of premature mortality. Hence, the issue 
of measuring premature mortality is not solely related 
to goodness of fit, and the definition of the benchmark 
(i.e. the senescent mortality curve) appears to be far more 
important. Inspecting the results obtained for all con-
sidered countries (see Fig.  5), we notice that using this 
approach, premature mortality  in the USA  is much 
higher than in other countries. Moreover—differently 
from what was suggested based on absolute and relative 
measures—it appears that this alternative measure shows 
a stagnation of premature mortality, which remains at 
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Fig. 5 Prevalence of premature mortality in selected countries, using absolute, relative and hierarchical approach (source: Own elaborations from 
HMD)
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A particularly high premature mortality is recorded 
also in Denmark and (somewhat lower, yet increasing) in 
the Netherlands. These results are not too surprising: the 
high prevalence of premature mortality in the USA is in 
line with what has been shown by Case and Deaton [14, 
29]. We also know that Denmark underwent a stagnation 
of life expectancy [32] between 1980 and 2000 (in par-
ticular for women, but also for men), and a similar one 
was observed in the Netherlands [33]. Thus, this hierar-
chical modeling approach not only provides a “reconcili-
ation” between “relative” and “absolute” approaches, but 
also provides premature mortality results which are argu-
ably more in line with existing research insights on   the 
specific countries.
Composition of groups
An important choice to be made when implementing the 
hierarchical model is the composition of the group of 
countries who will share the same “senescent” mortality. 
In the above application, we created a group character-
ized by high longevity, although other choices could also 
have been taken. To extend the application and to illus-
trate the challenge of creating groups, we have applied 
the same model to most recent data of Latin American 
populations taken from the  Latin American Mortal-
ity database (LAMBdA) [34]. In this case, groups have 
been defined by combining countries with (1) a rela-
tively high longevity (Chile, Costarica, Cuba, Ecuador, 
Mexico, Panama), (2) medium longevity (Argentina, Bra-
zil, Chile,Colombia, Dominican Republic, Peru and Ven-
ezuela) and (3) lower longevity (El Salvador, Guatemala 
and Nicaragua). Figures  7, 8 and 9 show the estimates 
of the senescent and premature curves. This definition 
of clusters has also been determined on the basis of the 
model’s goodness-of-fit to the data: if a country has a 
mortality profile that is very different from the others in 
the group, the model would not fit adequately. The ref-
erence senescent mortality curves are defined by pooling 
all the countries of the same group.
In Table 1, we reported also the R-hat statistic [35] for 
the premature mortality parameter only, and the results 
confirm a satisfying fit (R-hat statistic with a value 
around 1 suggest a good mixing of the Markov chain 
and, therefore, a good fit of the model). However, it is 
possible to change the composition of the groups keep-
ing an adequate goodness of fit. For example, Chile has 
been included both in the high and medium longevity 
group: in the former, Chile has the highest level of pre-
mature mortality (29.5%), according to the hierarchical 
approach, while in the medium longevity group, it has 
the lowest (10.7%). This means that although statistical 
measures of fit can assist in a more data driven rather 
than subjective group assignment, ultimately there will 
typically remain an element of subjective discretion that 
can critically affect a country’s relative “performance”. 
Inevitably, belonging to a high longevity country makes 
it more challenging to keep premature mortality low, as 
the senescent mortality is shifted further to the right, 
while belonging to a low longevity group makes it eas-
ier. Therefore, there is no single “perfect” composition 
of possible clusters, and for any country belonging to 
a group or another will make the difference in terms 
of premature mortality estimate. Hence, the choice of 
grouping will require careful reasoning and transpar-
ency. However, this flexibility ensures that countries 
are not confined to a specific group, but can be com-
pared with different groups. Moreover, after having 
defined the criteria to create the groups, countries can 
move from one group to another as their mortality pat-
tern evolves. Hence, this approach does not exclude the 
possibility that, in the long run, a low longevity country 
like a sub-Saharian may be comparable to a high lon-
gevity country, such as Japan.
Choosing reference senescent mortality
Another critical choice is about the reference senes-
cent mortality distribution that is used to define the 
premature mortality distribution. One possibility is to 
pool all the countries of a given group together and use 





























































Fig. 6 France and USA 2011, Senescent and premature mortality 
curves using the hierarchical approach (source: Own elaborations 
from HMD)
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distribution. An alternative could be to choose one 
country as a reference, for example, the country with 
the highest life expectancy (or the highest modal age at 
death). Once again, the choice may be partly guided by 
the goodness of fit: using an average distribution tends 
to make it easier to have a good fit also for the lowest 
longevity country, but, on the other hand, having as 
a benchmark a real country (e.g. Sweden) senescent 
mortality distribution would facilitate the interpreta-
tion of premature mortality prevalence figures, as the 
“super-population” senescent mortality might be dif-
ficult to conceptualise and communicate. There may, 
however, be cases, in which the “super-population” 
serves as a very meaningful concept: for example, if 
sub-national data are considered (regions or provinces), 
then pooling them together provides a picture of the 
entire country, and prevalence of premature mortality 
can be calculated with respect to the national senescent 
mortality distribution. Hence, the choice of the right 





















































































































































































Fig. 7 Prevalence of premature mortality in some Latin American countries (high longevity group), hierarchical approach (source: Own 
elaborations from LAMBdA)
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Discussion
Classifying the previously used approaches into “abso-
lute” versus “relative” ones, we point out limitations 
in either approach. To overcome those, we propose a 
hybrid approach that draws out useful elements of both 
the absolute and relative approach. This new approach 
assumes senescent mortality to be fixed for all the coun-
tries considered as sufficiently “homogeneous”, while 
the premature mortality curve is allowed to vary across 
countries. It is hybrid, in the sense that it defines prema-
ture mortality relative to the benchmark that is chosen, 
but it is also an absolute measure among those countries 
that are compared with the same benchmark.
As a result, while our hybrid approach overcomes 
some of the problems of the previous measures, it is not 
perfect either—and neither could one expect it to be, 
in light of the latent nature of the concept. Particularly, 















































































































































































































































































Fig. 8 Prevalence of premature mortality in some Latin American countries (medium longevity group), hierarchical approach (source: Own 
elaborations from LAMBdA)
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the group a given country is assigned to. While statistical 
testing of model fit can aid in those decisions to a degree, 
there remains an inevitable degree of arbitrariness that, 
however, can and should be explicitly addressed and 
made transparent in its application. For example, Leger 
and Mazzuco  [36] propose a functional clustering of 
countries’ age distribution of deaths, offering a data-
driven way to create groups which are maximally homo-
geneous, and this—or other equivalent methods, can be 
used as a starting point for creating country groups. An 
alternative is to embed a model-based clustering into 
the hierarchical model, so that premature mortality esti-
mates and groups’ composition are determined jointly. 
This is certainly an avenue fur future research.
The results we get here look consistent with findings 
of other scholars who analyzed some specific countries, 
and there is scope for explaining the trend of prema-
ture mortality we get in Fig. 5 for several countries. For 
instance, the evolution of premature mortality can be 
explained in terms of evolution of causes of death. This 
is another avenue of research that will be explored.
Conclusion
Premature mortality is a latent concept, and as such 
cannot be truly observed. As we have shown, how the 
concept is precisely operationalized may well qualita-
























































































Fig. 9 Prevalence of premature mortality in some Latin American countries (low longevity group), hierarchical approach (source: Own elaborations 
from LAMBdA)
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country may be judged to have done “better” than a 
different country in terms of one measure of prema-
ture mortality, but worse according to another meas-
ure. Likewise, in assessing a country’s “progress” in 
tackling premature mortality over time (e.g. in the 
context of the SDG progress assessments), that pro-
gress may be assessed differently, depending on the 
exact measure that is employed. As the concept of pre-
mature mortality enjoys such (understandable) popu-
larity in international comparisons and benchmarking 
purposes, it seems critical to use a measure that is as 
reliable as possible. Our proposed method, combined 
with further study addressing the clustering issue, 
could provide a valid alternative way to measure and 
compare premature mortality across countries.
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